A controlled trial of extended radical versus radical mastectomy. Ten-year results
โ Scribed by Paul Meier; Donald J. Ferguson; Theodore Karrison
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 693 KB
- Volume
- 63
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
In view of increasing debate over possible benefit of more complete surgery compared to conservative procedures, a randomized controlled trial contrasting the then standard Halsted radical (RDL) operation with the more complete extended radical (EXT) mastectomy was initiated in 1973. Between November 1973 and July 1982,123 women younger than 70 years of age and at clinical Stages I and I1 were enrolled.
Of the total series, 112 were treated by the same surgeon and confirmed pathologically as having invasive mammary carcinoma. In this more homogeneous subgroup, the 10-year survival rates (and standard errors) were for RDL, 60% (+7%) and for EXT, 74% (+6%) (P value for comparison of survival curves = 0.13). In patients from this subgroup with central-medial tumors, comprising 62% of the total, survival after RDL at 10 years was 60% (+8%), and after EXT 86% (+6%) (P = 0.025). In the remaining patients with lateral tumors, survival rates were unaffected by treatment: 58% (+13%) and 56% (+11%), respectively (P = 0.62). Comparison of a nonrandomized series of 266 RDL and 124 EXT patients treated between 1960 and 1978 found differences consistent with those of the randomized study, although not statistically significant.
๐ SIMILAR VOLUMES
## Abstract A controlled clinical trial has been performed to compare the effectiveness of suction drainage with that of static drainage. The trial has shown that in 53 radical mastectomy wounds the rate of wound healing was faster in those cases in which suction drainage was used, with a reduction
Primary biliary cirrhosis frequently progresses despite treatment with ursodeoxycholic acid (UDCA), the only approved therapy. Previous studies suggested that colchicine and methotrexate may improve biochemical tests of liver function, symptoms, and liver histology. The aim of the present study was